C/O Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN
Summary
The estimated net worth of Jacob Van Naarden is at least $20.8M dollars as of November 1, 2024. Jacob Van Naarden is the EVP & Pres., Lilly Oncology of ELI LILLY & Co and owns shares of ELI LILLY & Co (LLY) stock worth about $20.8M.
Insider Transactions Reported by Jacob Van Naarden:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.